Consensus NuCana plc

Equities

NCNA

US67022C2052

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-10 pm EDT			5-day change	1st Jan Change
3.59 ^USD	+2.57%		-10.25%	-51.45%

May. 10	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	MT
May. 09	European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	MT

Evolution of the average Target Price on NuCana plc

Price target over the last 5 years

History of analyst recommendation changes

aa2411e64a50f7.7XziKige5XoYSSb7gTncUczdXksLZdYhKW72UhzpjaE.2UTUG1gruhIhAVDPxkjkFa-aDgJfK5lrbTyTP3qs4MKrI6sca3yIHUcDHg~9ae3202bfd3952d4add74d4c0160d89b

Analyst Recommendations on NuCana plc

American Depositary Receipts of European Equities Advance Slightly Before US Rate Decision	23-03-22	MT
ECB, Bank of England Interest Rate Hikes Weigh Down European Equities	22-12-15	MT
Oppenheimer Trims NuCana's Price Target to $4 From $5, Maintains Outperform Rating	22-11-21	MT
Jefferies & Co. Adjusts NuCana's Price Target to $3 From $21, Keeps Buy Rating	22-09-22	MT
Truist Securities Adjusts NuCana's Price Target to $6 From $22, Reiterates Buy Rating	22-04-13	MT
Oppenheimer Adjusts NuCana Price Target to $5 From $19, Maintains Neutral Rating	22-03-14	MT
Cowen Downgrades NuCana to Market Perform From Outperform	22-03-03	MT
HC Wainwright Adjusts NuCana's Price Target to $9 From $10, Keeps Buy Rating	21-11-24	MT
NUCANA : HC Wainwright Adjusts NuCana's Price Target to $10 From $15, Keeps at Buy	20-12-01	MT
NuCana : Says Final Data From Phase Ib Trial of Advanced Biliary Tract Cancer Treatment Show High Objective Response Rate	20-11-30	MT
NUCANA : HC Wainwright Adjusts NuCana's Price Target to $15 From $17, Keeps at Buy	20-11-24	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.59 USD

Average target price

119.8 USD

Spread / Average Target

+3,237.98%

High Price Target

150 USD

Spread / Highest target

+4,078.27%

Low Price Target

100 USD

Spread / Lowest Target

+2,685.52%

Consensus detail

Consensus revision (last 18 months)

Analysts covering NuCana plc

Oppenheimer
Jefferies & Co.
Truist Securities
Cowen
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar